Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Legacy Education (LGCY) Prices 2.5M Share IPO at $4/sh
-
Legacy Education Inc. Announces Pricing of Initial Public Offering
-
DTE Energy (DTE) PT Raised to $139.50 at Ladenburg Thalmann
-
OFS Credit Company, Inc. Prices Preferred Stock Offering
-
OFS Credit (OCCI) Commences Preferred Share Offering
-
OFS Credit Company, Inc. Commences Preferred Stock Offering
-
Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) to Buy
-
Corvus Pharmaceuticals (CRVS) PT Raised to $21 at Ladenburg Thalmann
-
Ladenburg Thalmann Upgrades Acrivon Therapeutics Inc (ACRV) to Buy, 'Impressive Endometrial Responses'
-
Great Elm Capital Corp. Prices Public Offering of $36,000,000 of 8.125% Notes Due 2029
-
Great Elm Capital (GECC) Announces Proposed Notes Offering
-
Great Elm Capital Corp. Announces Public Offering of Unsecured Notes
-
Ladenburg Thalmann Starts Atmos Energy (ATO) at Buy
-
Catheter Precision, Inc. Announces Closing of $3.6 Million Underwritten Public Offering and Exercise of Overallotment Option
-
Form N-PX LADENBURG THALMANN ASSET For: Jun 30
-
Catheter Precision, Inc. Announces Pricing of $3.1 Million Underwritten Public Offering
-
Nuwellis (NUWE) Prices $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Ladenburg Thalmann Starts DTE Energy (DTE) at Buy
-
Form 13F-NT LADENBURG THALMANN ASSET For: Jun 30
-
Ladenburg Thalmann Upgrades Alliant Energy (LNT) to Buy 'based on potential earning upside from the company’s Iowa settlement'
-
Synchronoss Technologies (SNCR) PT Raised to $40 at Ladenburg Thalmann
-
Ausdal Financial Partners Welcomes William LaPiana as Newest Certified Exit Planner (CEPA)
-
Ladenburg Thalmann Upgrades Public Service Enterprise Group Inc. (PEG) to Buy
-
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
-
NovaBay Pharma (NBY) Announces Pricing of $3.5 Million Underwritten Public Offering
-
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
-
Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
-
Biodexa Pharmaceuticals (BDRX) Prices $5 Million Registered Direct Offering and Concurrent Private Placement
-
Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
-
Trinity Capital Inc. Prices Offering of $100.0 Million of 7.875% Notes due 2029
-
Kingswood U.S. Continues Expansion of Successful In-House Investment Banking Group with Appointment of Tony Tian as Senior Managing Director
-
Osaic Launches Advanced Retirement Income Planning Platform
-
NovaBay Pharma (NBY) Reports Prelim Q2 Revenue of $2.4M
-
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
-
Saratoga Investment Corp. Announces Fiscal First Quarter 2025 Financial Results
-
Ardelyx, Inc (ARDX) PT Lowered to $12.50 at Ladenburg Thalmann
-
Oxford Lane Capital Corp. Prices Public Offering of $100,000,000 8.75% Notes Due 2030
-
Osaic Affiliate Welcomes Engler, Garrow & Roth, Ltd., and Hartmann•Bogan Financial Planning
-
Sonnet BioTherapeutics (SONN) Receives $3.4M From Warrants Exercise
-
Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
-
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
-
UroGen Pharma (URGN) Commences Share and Warrant Offering
-
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
-
Ladenburg Thalmann Downgrades Coeptis Therapeutics Holdings, Inc. (COEP) to Neutral
-
UroGen Pharma (URGN) PT Raised to $53.50 at Ladenburg Thalmann
-
Ladenburg Thalmann Starts Red Cat Holdings Inc. (RCAT) at Buy
-
Ladenburg Thalmann Downgrades Entergy Corp (ETR) to Neutral
-
Ladenburg Thalmann Upgrades American Electric Power (AEP) to Neutral
-
Ladenburg Thalmann Upgrades Pinnacle West Capital (PNW) to Buy

